The U.S. inflation data released in June has significantly altered the trajectory of Federal Reserve policy expectations, with headline CPI declining by 0.4% month-over-month and annual growth easing to 3.5%. This performance, while still above the 2.4% target, represents a material moderation compared to May’s 4.2% reading, driven primarily by a 5.7% annual drop in energy prices as gasoline costs fell to $3.70 per gallon. Core inflation, excluding volatile energy and food, remained flat at 2.6%, signaling no broad-based acceleration in price pressures. These developments have emboldened markets, as evidenced by the S&P 500’s 0.3% gain, Nasdaq’s 0.9% rise, and the Dow’s marginal uptick, while Treasury yields retreated to 4.6% amid diminished urgency for rate hikes. The Federal Reserve’s Beige Book further underscored this shift, with regional bankers emphasizing the need to “hold off” on tightening despite lingering uncertainties tied to geopolitical tensions in the Middle East.
The earnings season has unfolded with stark sectoral divergences, epitomized by the tech sector’s resilience versus the existential crisis facing IBM. IBM’s 25% plunge followed a warning that clients are reallocating capital toward AI infrastructure, reflecting a broader industry recalibration as firms prioritize hardware and memory investments to secure supply chains ahead of anticipated price hikes. Conversely, AI-driven growth has buoyed chipmakers like ASML, whose Q2 earnings beat expectations on robust demand for semiconductor equipment, and data center operators such as Equinix, which saw shares surge 30% on strong order intake. The contrast between IBM’s struggles and the AI ecosystem’s expansion highlights a structural shift in corporate priorities, with capital expenditures increasingly directed toward infrastructure that underpins emerging technologies. Meanwhile, financial institutions have capitalized on heightened deal activity, with Goldman Sachs reporting a 55% year-over-year surge in investment banking fees, driven by record pipelines and strategic M&A advisory roles.
Geopolitical risks remain a critical wildcard, particularly as the U.S.-Iran standoff escalates following Tehran’s threats to restrict Strait of Hormuz traffic. While crude prices stabilized after a brief spike, the potential for renewed conflict introduces volatility into energy markets, complicating inflation forecasts. Simultaneously, regulatory scrutiny of AI infrastructure projects has intensified, with New York’s moratorium on data centers—targeting facilities consuming 50 megawatts or more—mirroring national debates over resource allocation. These local and global pressures underscore the fragility of economic recovery, as policymakers balance inflation control with the imperatives of technological advancement and energy security. The interplay between monetary policy, corporate strategy, and geopolitical dynamics will define market outcomes in the coming months, demanding vigilance from investors navigating an increasingly fragmented landscape.
The divergence in corporate performance further illustrates the uneven recovery across sectors, with AI-related firms outperforming legacy technology companies. PayPal’s $53 billion acquisition offer, backed by Stripe and Advent International, exemplifies the consolidation trend in digital payments, while banks like JPMorgan and Goldman Sachs report record deal volumes amid renewed confidence in M&A activity. However, this optimism is tempered by macroeconomic headwinds, including a 15% rise in corporate credit card delinquencies and the Federal Reserve’s cautious stance on rate hikes despite lingering inflationary risks. The June CPI data, though encouraging, remains insufficient to dismiss long-term concerns about supply-chain bottlenecks and energy market volatility. As central banks grapple with conflicting signals—cooling inflation versus persistent geopolitical tensions—investors must weigh the potential for policy surprises against the structural shifts reshaping industries. The convergence of these factors suggests a market environment defined by both opportunity and uncertainty, where adaptability will be paramount for firms and policymakers alike.
IanFV (www.ianfv.com) is the world's first pure-blood, neutral research institution built on LLM (Large Language Models) specifically for individual investors. Founded by a top-tier team with backgrounds from Tsinghua, Harvard, Morgan Stanley, and UBS, we are committed to breaking down high-priced information barriers and providing institutional-grade investment research at affordable prices. Unlike traditional institutions, IanFV does not serve big-money sponsors or inflate market bubbles. Leveraging a proprietary knowledge graph and a fully localized deployment architecture, we achieve a differentiated competitive advantage through light assets and high efficiency. Our research reports refuse to "sell dreams": valuation reports are based on point-in-time intervals rather than reverse-engineered numbers; industry reports focus relentlessly on real trends over the next six to twelve months; and in-depth reports penetrate market bubbles to strike at the core of corporate survival moats—all to ensure investors hold the most authentic research cards in the secondary market.
Watch List
NUVL
On July 15, 2026, this report confirms the completion of a merger between the Company and Parent, resulting in the Company becoming a wholly-owned subsidiary of Parent. The transaction, valued at approximately $10.6 billion, was financed through borrowings under Parent’s credit facilities. At the “Effective Time,” all outstanding shares of the Company, excluding those held by the company itself, Ultimate Parent, Parent, Purchaser, or stockholders demanding appraisal, were converted into cash equal to the Offer Price less applicable taxes. Consequently, the Company’s board of directors and officers resigned, while Justin T. Huang and Kevin T. Ryan, directors of Purchaser, assumed those roles within the newly merged entity. The Company’s governing documents – its certificate of incorporation and bylaws – were fully amended and restated as part of the merger agreement. This change in control was triggered by the consummation of the Offer and Merger, marking a significant shift in the Company’s corporate structure.
PLBC
Plumas Bancorp, the parent company of Plumas Bank, reported record-breaking second-quarter 2026 earnings of $9.9 million, a significant increase from $6.3 million in the prior year, driven by a substantial rise in net interest income to $26.0 million. Diluted earnings per share also climbed to $1.41, up from $1.05. The company’s strong performance reflected a return on average assets of 1.79% and a robust return on average equity of 15.0%, both improvements over 2025 figures. Key factors contributing to this success included a 49% increase in gross loans, largely due to the acquisition of Cornerstone Community Bank, alongside a 38% rise in total deposits. Non-interest income also saw an increase, boosted by FHLB dividends and interchange income. However, non-interest expense rose by $3.5 million, primarily due to the integration of Cornerstone. The bank maintained a solid capital position and continues to focus on asset quality, despite a slight increase in non-performing assets. Looking ahead, the CEO expressed optimism about continued growth, leveraging the bank’s relationship-based model and expanded franchise following the Cornerstone acquisition. The company’s net interest margin increased to 5.13% for the three-month period ending June 30, 2026, demonstrating effective management of interest rate risk. Additionally, the company reported net income of $19.7 million for the six months ended June 30, 2026, an increase from $13.5 million in the prior period.
FHN
First Horizon Corporation reported a strong second quarter of 2026, achieving net income available to common shareholders of $260 million, a 12% increase year-over-year, and an EPS of $0.54, up from $0.45 in the prior year. This performance reflects disciplined execution and a focus on client relationships, resulting in 3% year-over-year loan growth and a 16% increase in net income available to common shareholders compared to the first half of 2025. The company’s return on common equity and return on tangible common equity both rose to 12.3% and 15.2%, respectively. Key highlights included an increase in net interest income to $679 million, driven by loan portfolio growth, alongside a 3.49% net interest margin that decreased slightly due to higher deposit costs. Noninterest income also saw an increase, primarily from brokerage, trust, and insurance activities, alongside deferred compensation income. However, expenses increased by $26 million, largely due to higher outside services and deposit costs. Loan and lease balances grew by $1.5 billion, with average deposits increasing by $572 million. The company maintained a CET1 ratio of 10.5% and deployed capital into loan growth and share repurchases. Notable items, including Visa derivative valuation expenses and deemed dividend impacts related to preferred stock redemptions, impacted the results. First Horizon continues to focus on its core business segments – Commercial, Consumer & Wealth, and Corporate – with the Corporate segment supporting the company’s overall operations.
CAG
Conagra Brands, Inc. recently filed Form 8-K with the SEC to disclose its fourth-quarter fiscal 2026 financial results. This filing, furnished as Exhibit 99.1, mirrors information released in a press release issued on July 15, 2026. While specific financial details weren't included directly within the filing itself, the document serves as notification of the company’s performance update. Investors and stakeholders can access the full details of Conagra Brands’ fourth-quarter results through the press release accompanying this Form 8-K. The filing confirms the company’s commitment to transparency and providing timely updates regarding its financial standing and operational performance.
ELV
Elevance Health, Inc. reported a strong second quarter of 2026, exceeding expectations with operating revenue up 0.8% to $49.8 billion, driven by Health Benefits segment gains and CarelonRx product revenue. As a result, the company raised its full-year 2026 adjusted diluted EPS guidance to at least $27.00, up from previously $20.10, reflecting this positive performance. Elevance is accelerating investments in key areas including medical cost management, member experience, and provider connectivity, alongside strengthening its Carelon’s integrated solutions. Operating cash flow guidance was also increased to at least $6.0 billion. The company’s operating gain increased by 1 percent year over year, primarily due to improved profitability in its specialty pharmacy. Membership decreased slightly, primarily due to commercial fee-based customer transitions. Elevance continues to focus on operational efficiency and strategic investments to support long-term growth, aiming for at least 12% adjusted EPS growth in 2027. The company’s financial position remains strong with $2.1 billion in cash and investments and $5.3 billion remaining in share repurchase authorization.
AXSM
Axsome Therapeutics, Inc. has announced a significant advancement in its pipeline with the U.S. Food and Drug Administration’s acceptance of the New Drug Application (NDA) for AXS-12, a reboxetine formulation, for the treatment of cataplexy associated with narcolepsy. This acceptance marks a key step forward in the company’s efforts to address this unmet medical need. The announcement, released on July 15, 2026, was accompanied by the filing of a full press release as Exhibit 99.1, which is incorporated into this report for comprehensive detail. This development is anticipated to bolster Axsome Therapeutics’ strategy and potential for commercial success within the neurological disorder space. Investors and stakeholders will be closely monitoring the progress of the NDA review process as it moves toward potential approval.
PKX
POSCO, headquartered at its center in Seoul, South Korea, recently announced provisional earnings and its business plan for the second quarter of 2026. The announcement, made on July 30th at 3:00 PM KST, was primarily targeted towards analysts, institutional investors, and the press. While specific financial details weren't disclosed in this preliminary notice, it signals a forthcoming update regarding the company’s performance during the period. This announcement suggests POSCO is preparing to share key business strategies and potentially revised forecasts for the remainder of the year. The timing of the release – late July – indicates a proactive approach to transparency and communication with key stakeholders as the company navigates the evolving market landscape. Further details regarding the company’s performance and future plans will be revealed in a subsequent official filing.
WS
Worthington Steel, Inc. has initiated a public tender offer to delist Klöckner & Co SE, a German stock corporation, from the stock market. The offer, facilitated by Worthington Steel GmbH, a wholly-owned subsidiary, seeks to acquire all outstanding shares not already held by Worthington Steel. This move follows the approval of the Delisting Offer Document by Germany’s Federal Financial Supervisory Authority (Bafin). Worthington Steel emphasized that this announcement does not constitute an offer to purchase shares and advises investors and Klöckner shareholders to carefully review the full offer document, available as Exhibit 99.1, for comprehensive details regarding the terms of the tender offer. It’s important to note that while the Bidder has outlined key terms, they retain the right to modify these terms within legally permissible limits. This delisting attempt represents a significant strategic move by Worthington Steel, aiming to consolidate its holdings and potentially reshape its corporate structure.
GUTS
Fractyl Health, Inc. recently announced promising one-year results from its REMAIN-1 Midpoint Cohort study evaluating its Revita DMR System for weight maintenance following GLP-1 discontinuation. The blinded, sham-controlled study, involving 45 participants, demonstrated a significant reduction in weight regain – approximately 40% – for those receiving the Revita procedure compared to the sham group, with a least-squares mean weight regain of 7.8% versus 13.0% of body weight. Notably, patients with complete duodenal ablation exhibited even greater durability, maintaining roughly 81% of their initial weight loss compared to 48% in the sham group. These findings, particularly for those with higher initial weight loss, suggest a heightened benefit from the Revita treatment. Furthermore, the study revealed a responder rate of 91% in the optimized population with complete duodenal ablation, mirroring a 73% rate observed in the Pivotal Cohort. Importantly, the study reported no serious adverse events related to the device or procedure, and overall TEAE rates were comparable between the Revita and sham groups. A new diagnosis of type 2 diabetes was observed in the sham arm, highlighting a potential benefit of the Revita intervention. Fractyl Health plans to host a conference call to discuss these results further.
Economic Calendar
IanFV (www.ianfv.com) is the world's first pure-blood, neutral research institution built on LLM (Large Language Models) specifically for individual investors. Founded by a top-tier team with backgrounds from Tsinghua, Harvard, Morgan Stanley, and UBS, we are committed to breaking down high-priced information barriers and providing institutional-grade investment research at affordable prices. Unlike traditional institutions, IanFV does not serve big-money sponsors or inflate market bubbles. Leveraging a proprietary knowledge graph and a fully localized deployment architecture, we achieve a differentiated competitive advantage through light assets and high efficiency. Our research reports refuse to "sell dreams": valuation reports are based on point-in-time intervals rather than reverse-engineered numbers; industry reports focus relentlessly on real trends over the next six to twelve months; and in-depth reports penetrate market bubbles to strike at the core of corporate survival moats—all to ensure investors hold the most authentic research cards in the secondary market.
| Date | Event | Previous | Impact |
|---|---|---|---|
| 2026-07-15 07:00:00 | MBA Mortgage Market Index (Jul/10) | 266.300 | ⭐️ |
| 2026-07-15 07:00:00 | MBA Purchase Index (Jul/10) | 169.500 | ⭐️ |
| 2026-07-15 07:00:00 | MBA 30-Year Mortgage Rate (Jul/10) | 6.580 | ⭐️⭐️ |
| 2026-07-15 07:00:00 | MBA Mortgage Applications (Jul/10) | -2.200 | ⭐️ |
| 2026-07-15 07:00:00 | MBA Mortgage Refinance Index (Jul/10) | 794.400 | ⭐️ |
| 2026-07-15 08:30:00 | PPI Ex Food, Energy and Trade YoY (Jun) | 5.100 | ⭐️ |
| 2026-07-15 08:30:00 | NY Empire State Manufacturing Index (Jul) | 5.700 | ⭐️⭐️ |
| 2026-07-15 08:30:00 | Core PPI YoY (Jun) | 4.600 | ⭐️ |
| 2026-07-15 08:30:00 | Producer Price Index (Jun) | 157.001 | ⭐️ |
| 2026-07-15 08:30:00 | PPI Ex Food, Energy and Trade MoM (Jun) | 0.800 | ⭐️ |
| 2026-07-15 08:30:00 | Producer Price Index YoY (Jun) | 6.000 | ⭐️ |
| 2026-07-15 08:30:00 | Core PPI MoM (Jun) | 0.100 | ⭐️⭐️ |
| 2026-07-15 08:30:00 | Producer Price Index MoM (Jun) | 0.600 | ⭐️⭐️⭐️ |
| 2026-07-15 08:45:00 | Fed Williams Speech | NaN | ⭐️⭐️ |
| 2026-07-15 10:30:00 | EIA Crude Oil Stocks Change (Jul/10) | 2.998 | ⭐️⭐️ |
| 2026-07-15 10:30:00 | EIA Gasoline Stocks Change (Jul/10) | -1.904 | ⭐️⭐️ |
| 2026-07-15 10:30:00 | EIA Crude Oil Imports Change (Jul/10) | 1.096 | ⭐️ |
| 2026-07-15 10:30:00 | EIA Cushing Crude Oil Stocks Change (Jul/10) | -0.052 | ⭐️ |
| 2026-07-15 10:30:00 | EIA Distillate Fuel Production Change (Jul/10) | -0.001 | ⭐️ |
| 2026-07-15 10:30:00 | EIA Gasoline Production Change (Jul/10) | -0.233 | ⭐️ |
| 2026-07-15 10:30:00 | EIA Heating Oil Stocks Change (Jul/10) | -0.427 | ⭐️ |
| 2026-07-15 10:30:00 | EIA Refinery Crude Runs Change (Jul/10) | -0.172 | ⭐️ |
| 2026-07-15 10:30:00 | EIA Distillate Stocks Change (Jul/10) | -4.980 | ⭐️ |
| 2026-07-15 10:30:00 | Crude Oil Imports | 1.096 | ⭐️ |
| 2026-07-15 10:30:00 | EIA Weekly Refinery Utilization Rates WoW | -0.800 | ⭐️ |
| 2026-07-15 11:30:00 | 17-Week Bill Auction | 3.790 | ⭐️ |
| 2026-07-15 13:00:00 | Fed Cook Speech | NaN | ⭐️⭐️ |
| 2026-07-15 14:00:00 | Beige Book | NaN | ⭐️⭐️ |
| 2026-07-15 14:00:00 | Fed Beige Book | NaN | ⭐️ |
| 2026-07-15 18:30:00 | Fed Musalem Speech | NaN | ⭐️⭐️ |